4.6 Article

XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer

期刊

GYNECOLOGIC ONCOLOGY
卷 111, 期 3, 页码 509-515

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2008.08.034

关键词

Polymorphism; Single nucleotide; Uterine cervical neoplasms; Neoadjuvant therapy; Drug therapy; Dose-response relationships; Drug

资金

  1. Seoul National University Hospital Research [04-2006-040]

向作者/读者索取更多资源

Objective. The objective of this study was to evaluate the association of single nucleotide polymorphisms (SNPs) of genes which are involved in DNA synthesis and repair with the response to platinum-based neoadjuvant chemotherapy (NAC) and disease-free survival (DFS) in patients with cervical cancer who were treated with NAC followed by radical hysterectomy. Methods. A retrospective review was performed on 66 patients with cervical cancer who were treated with NAC followed by radical hysterectomy in our institute between January 1999 and February 2007. DNA was extracted from the paraffin-embedded, formalin-fixed tissue blocks of hysterectomy specimens. The genotypes of SNPs (MTHFR 677Cytosine/Thymine, XRCC1 Arginine194Tryptophan, GGH-401Cytosine/Thymine, and GSTP1 Isoleucine105Valine) were determined using a single base primer extension assay. The association of SNP genotypes with the response to NAC, which was measured by physical and colposcopic examinations, was evaluated. In addition, DFS based on SNP genotypes was examined. Results. The genotypes of XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine were significantly associated with the response to NAC (P=0.023 for XRCC1 Arginine194Tryptophan; P=0.046 for GGH-401Cytosine/Thymine). However, the genotypes of MTHFR 677Cytosine/Thymine and GSTP1 Isoleucine105Valine were not associated with the response to NAC. In subgroup analysis with 39 patients who were treated with regimens containing 5-fluorouracil (5-FU), the genotypes of GGH-401Cytosine/Thymine were significantly associated with the response to NAC (P=0.039). In multifactor dimensionality reduction (MDR) analysis, the combination of XRCC1 Arginine 194Tryptophan and GGH-401Cytosine/Thymine genotypes was associated with the response to NAC (P<0.001). However, no SNP genotypes were associated with DFS, but the cisplatin dose intensity of NAC was associated with DFS. Conclusions. The genotypes of XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine were associated with the response to NAC in patients with cervical cancer. However, no SNP genotypes were associated with DFS. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Clinical adhesion score (CLAS): development of a novel clinical score for adhesion-related complications in abdominal and pelvic surgery

Elisabeth Jacomine Lier, Barend A. W. van den Beukel, Larsa Gawria, Philip J. van der Wees, Leontine van den Hil, Nicole D. Bouvy, Ying Cheong, Rudy-Leon de Wilde, Harry van Goor, Martijn W. J. Stommel, Richard P. G. ten Broek

Summary: The study developed a new clinical adhesion score (CLAS) to measure the overall clinical morbidity of adhesion-related complications in abdominal and pelvic surgery. Through Delphi study and pilot study, the CLAS includes 22 outcomes and 23 weight factors, correcting the likelihood of symptoms being related to adhesions through scoring.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Article Oncology

A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer

Hee Seung Kim, Sang-Yoon Park, Chan-Yong Park, Young Tae Kim, Beob-Jong Kim, Yong Jung Song, Byoung-Gie Kim, Yong Beom Kim, Chi-Heum Cho, Jong-Hyeok Kim, Yong Sang Song

Summary: This Phase 2b study compared the efficacy and toxicity of belotecan and topotecan in recurrent ovarian cancer, showing that belotecan was not inferior to topotecan in terms of overall response rate. Additionally, belotecan was associated with improved overall survival compared with topotecan, especially in patients with PRROC and non-HGSC. Toxicity did not differ significantly between the two treatment groups.

BRITISH JOURNAL OF CANCER (2021)

Article Plant Sciences

Piceatannol Is Superior to Resveratrol at Suppressing Adipogenesis in Human Visceral Adipose-Derived Stem Cells

In Sil Park, Youngjin Han, HyunA Jo, Ki Won Lee, Yong Sang Song

Summary: Resveratrol and piceatannol, major stilbene compounds found in natural foods, exhibit inhibitory effects on lipid accumulation and adipogenesis, with piceatannol showing superior anti-adipogenic properties compared to resveratrol in a model of visceral obesity.

PLANTS-BASEL (2021)

Article Oncology

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma

Suhyun Hwangbo, Se Ik Kim, Ju-Hyun Kim, Kyung Jin Eoh, Chanhee Lee, Young Tae Kim, Dae-Shik Suh, Taesung Park, Yong Sang Song

Summary: The study aimed to develop machine learning models predicting platinum sensitivity in patients with high-grade serous ovarian carcinoma (HGSOC). Six variables associated with platinum sensitivity were selected using clinical data from multiple hospitals, and the LR-based model was found to perform the best. A web-based nomogram was developed for clinical use based on the LR model results.

CANCERS (2021)

Article Oncology

Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

Chae Young Han, David A. Patten, Se Ik Kim, Jung Jin Lim, David W. Chan, Michelle K. Y. Siu, Youngjin Han, Euridice Carmona, Robin J. Parks, Cheol Lee, Li-Jun Di, Zhen Lu, Karen K. L. Chan, Ja-Lok Ku, Elizabeth A. Macdonald, Barbara C. Vanderhyden, Anne-Marie Mes-Masson, Hextan Y. S. Ngan, Annie N. Y. Cheung, Yong Sang Song, Robert C. Bast, Mary-Ellen Harper, Benjamin K. Tsang

Summary: This study highlights the functional interaction between HKII and activated P-p53 (Ser15) in the regulation of bioenergetics and chemosensitivity, emphasizing the increased nuclear HKII-P-p53 (Ser15) interaction as a potential prognostic biomarker in ovarian cancer.

CANCERS (2021)

Article Oncology

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer

Se Ik Kim, Sungyoung Lee, Chel Hun Choi, Maria Lee, Dong Hoon Suh, Hee Seung Kim, Kidong Kim, Hyun Hoon Chung, Jae Hong No, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Yong Beom Kim

Summary: The study developed models predicting survival outcomes according to the surgical approach for radical hysterectomy in early cervical cancer, with hybrid ensemble models performing the best.

CANCERS (2021)

Review Cell Biology

Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology

Revathy Nadhan, Ciro Isidoro, Yong Sang Song, Danny N. Dhanasekaran

Summary: This review summarizes the structure and function of long non-coding RNAs (lncRNAs) in cellular signaling networks, as well as their mechanisms of action. It provides insights into the pathogenesis of cardiovascular diseases, neurological disorders, cancers, and diabetes mellitus, highlighting the role of lncRNAs. The review suggests that lncRNAs could be potential therapeutic targets.
Review Oncology

EPIK-O/ENGOT-OV61: Alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)

Panagiotis A. Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, Michael Friedlander, Rosalind Glasspool, Domenica Lorusso, Christian Marth, Bradley J. Monk, Jae-Weon Kim, Patsy Hinson, Olga Ajipa, Vincent Pretre, Yu Han, Ursula A. Matulonis

Summary: This article describes a study investigating the combination of the specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib and the poly (adenosine diphosphateribose) polymerase (PARP) inhibitor olaparib in platinum-resistant or -refractory high-grade serous ovarian cancer (HGSOC) patients without germline BRCA mutation. The study aims to improve the prognosis of patients with this condition.

FUTURE ONCOLOGY (2022)

Article Oncology

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization

David Tan, Noriko Fujiwara, Keiichi Fujiwara, Philip Beale, Jae-Weon Kim, Joseph Ng, Se Ik Kim, Alison Evans, Byoung-Gie Kim

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE)

Soseul Sung, Youjin Hong, Byoung-Gie Kim, Ji-Yeob Choi, Jae Weon Kim, Sang-Yoon Park, Jae-Hoon Kim, Yong-man Kim, Jong-Min Lee, Tae Jin Kim, Sue K. K. Park

Summary: This study aimed to verify the association between ovarian cancer (OC) and reproductive- and lifestyle-related risk factors stratified by the subtype of OC. The results showed that smoking was positively associated with high-grade serous (HGS) OC, alcohol consumption was positively associated with mucinous type (MUC), and obesity was associated with clear cell type (CLC). Further, spontaneous abortion was negatively associated with CLC, while tubal ligation, hysterectomy, and oophorectomy were associated with decreased risk of HGS. Early menarche was strongly associated with increased risk of CLC. Additionally, childbirth, oral contraceptives, and hormone replacement therapy were negatively associated with OC.

CANCER MEDICINE (2023)

Review Biochemistry & Molecular Biology

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies

Revathy Nadhan, Srishti Kashyap, Ji Hee Ha, Muralidharan Jayaraman, Yong Sang Song, Ciro Isidoro, Danny N. Dhanasekaran

Summary: Peritoneal cancers pose significant challenges in clinical practice and have a poor prognosis. Understanding cancer cell metabolism and cancer-promoting metabolites in peritoneal cancers can provide new insights into tumor progression mechanisms, identify therapeutic targets and biomarkers, and improve treatment outcomes for patients.

METABOLITES (2023)

Article Cell Biology

N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer

Rebecca Yun, Eunji Hong, Junil Kim, Bora Park, Staci Jakyong Kim, Bona Lee, Yong Sang Song, Seong-Jin Kim, Sujin Park, Jin Muk Kang

Summary: This study reveals the crucial role of N-linked glycosylation in the functional post-translational modification of KIAA1324, which is important for suppressing cancer cell proliferation and migration in gastric cancer. Inhibition of glycosylation and fucosylation also inhibits KIAA1324-induced cell growth inhibition and apoptosis. Additionally, the study shows that N-linked glycosylation decreases protein stability through rapid proteasomal degradation. Overall, this research highlights the significance of post-translational modifications in KIAA1324 for gastric cancer progression.

CELL DEATH & DISEASE (2023)

Article Oncology

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

Jung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim

Summary: This study is an umbrella trial for platinum-resistant ovarian cancer, using biomarkers to determine patients' treatment. The results showed that all treatment combinations were manageable and clinically beneficial.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)

Review Oncology

Major clinical research advances in gynecologic cancer in 2021

Jeong-Yeol Park, Jung-Yun Lee, Yoo-Young Lee, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim

Summary: This review summarizes the major clinical research advances in gynecologic oncology, including treatment modalities and drug research for cervical cancer, ovarian cancer, and uterine corpus cancer. The study findings demonstrate the effectiveness and survival outcomes of new treatment strategies and drugs for these cancers.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)

Review Oncology

Major clinical research advances in gynecologic cancer in 2020

Yoo-Young Lee, Min Chul Choi, Jeong-Yeol Park, Dong Hoon Suh, Jae-Weon Kim

Summary: The review summarized major clinical research advances in gynecologic oncology in 2020, covering treatment progress and prevention strategies for cervical, ovarian, and uterine corpus cancers.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions

Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko

Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.

GYNECOLOGIC ONCOLOGY (2024)